Atlas Private Wealth Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Atlas Private Wealth Advisors’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-250	Closed	-$4K	–	744
2021 Q3	$4K	Hold	250	–	–	﹤0.01%	608
2021 Q2	$5K	Hold	250	–	–	﹤0.01%	586
2021 Q1	$6K	Hold	250	–	–	﹤0.01%	595
2020 Q4	$6K	Hold	250	–	–	﹤0.01%	506
2020 Q3	$10K	Hold	250	–	–	0.01%	395
2020 Q2	$12K	Buy	+250	New	+$19.3K	0.01%	389

Other funds holding ICPT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Atlas Private Wealth Advisors's ICPT Position: Q4 2021 in Review

Atlas Private Wealth Advisors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2021, closing a stake of 250 shares — an estimated $4K sold.

Atlas Private Wealth Advisors first reported a position in ICPT in Q2 2020 and held it in 6 quarters. The position peaked at $12K in Q2 2020. 147 funds tracked by Wall St. Rank hold ICPT as of Q4 2021.

Atlas Private Wealth Advisors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Atlas Private Wealth Advisors sold 250 Intercept Pharmaceuticals, Inc. shares in Q4 2021, an estimated $4K.
Atlas Private Wealth Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2020 and held it in 6 quarters.
Atlas Private Wealth Advisors's Intercept Pharmaceuticals, Inc. position peaked at $12K in Q2 2020.
147 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2021.

Based on Atlas Private Wealth Advisors's 13F filing for Q4 2021, filed 21 Apr 2022.